MIAMI, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $1.5 million in net revenues during September 2017.
PharmCo, LLC filled over 17,000 prescriptions during the month of September, generating over $1.5 million in net revenues. The company did not sustain any damage during Hurricane Irma and the Company’s staff worked to reach as many people as possible to see if they needed medication replacement or emergency supplies. Many doctor’s offices did not have power or internet services restored for several days following the storm, resulting in fewer new prescriptions for the month of September. Medical centers, doctors and patients have expressed gratitude to PharmCo and its staff for its dedicated effort in ensuring that patients in the South Florida community had adequate access and supply of emergency medication.
“Excellent customer service is the core of our business model,” stated S. Parikh Mars, CEO. “We made sure our drivers had full tanks of gas and our employees had sufficient water reserves, despite depleted supplies in the area, so that we could help our patients immediately before and after the storm. The company will continue to differentiate itself by always going to above and beyond as we work diligently to ensure our customers’ needs are met, especially in the face of natural disasters.”
About Progressive Care
Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
